CAS 186953-56-0: Pafuramidine
Description:Pafuramidine, also known by its developmental code name DB289, is a synthetic compound primarily investigated for its potential as an antiprotozoal agent, particularly against infections caused by Trypanosoma brucei, the causative agent of sleeping sickness. It belongs to the class of compounds known as diamidines, which are characterized by their ability to intercalate into DNA, thereby disrupting cellular processes. Pafuramidine exhibits a favorable pharmacokinetic profile, including good oral bioavailability and tissue distribution. Its mechanism of action involves the inhibition of nucleic acid synthesis in the target organisms. The compound has shown promise in preclinical studies and clinical trials, demonstrating efficacy against various protozoan infections. Additionally, it has been noted for its relatively low toxicity in comparison to other treatments. However, as with many investigational drugs, further studies are necessary to fully understand its safety, efficacy, and potential side effects in diverse populations. Overall, pafuramidine represents a significant advancement in the search for effective treatments for neglected tropical diseases.
Formula:C20H20N4O3
InChI:InChI=1S/C20H20N4O3/c1-25-23-19(21)15-7-3-13(4-8-15)17-11-12-18(27-17)14-5-9-16(10-6-14)20(22)24-26-2/h3-12H,1-2H3,(H2,21,23)(H2,22,24)
InChI key:InChIKey=UKOQVLAXCBRRGH-UHFFFAOYSA-N
SMILES:N=C(NOC)C=1C=CC(=CC1)C=2OC(=CC2)C=3C=CC(=CC3)C(=N)NOC
- Synonyms:
- 4,4′-(2,5-Furandiyl)bis[N-methoxybenzenecarboximidamide]
- Benzenecarboximidamide, 4,4′-(2,5-furandiyl)bis[N-methoxy-
- Pafuramidine
- 2,5-Bis(4-amidinophenyl)furan-bis-O-methylamidoxime
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | PAFURAMIDINE REF: IN-DA00ABL7CAS: 186953-56-0 | 98% | To inquire | Thu 27 Mar 25 |
![]() | Pafuramidine REF: TM-T16428CAS: 186953-56-0 | 98.34% | 97.00 €~838.00 € | Tue 01 Apr 25 |
![]() | Pafuramidine REF: TR-P133875CAS: 186953-56-0 | - - - | 475.00 €~2,262.00 € | Tue 08 Apr 25 |
![]() | Pafuramidine REF: 3D-FP76412CAS: 186953-56-0 | Min. 95% | 156.00 €~1,296.00 € | Mon 07 Apr 25 |

PAFURAMIDINE
Ref: IN-DA00ABL7
5mg | 315.00 € | ||
10mg | 497.00 € |

Pafuramidine
Ref: TM-T16428
1mg | 97.00 € | ||
5mg | 235.00 € | ||
10mg | 358.00 € | ||
25mg | 597.00 € | ||
50mg | 838.00 € | ||
1mL*10mM (DMSO) | 259.00 € |

Pafuramidine
Controlled ProductRef: TR-P133875
5mg | 475.00 € | ||
10mg | 696.00 € | ||
100mg | 2,262.00 € |

Pafuramidine
Ref: 3D-FP76412
10mg | 231.00 € | ||
25mg | 406.00 € | ||
50mg | 578.00 € | ||
100mg | 827.00 € | ||
250mg | 1,296.00 € |